Nanofiber micro-dispersed oxidized cellulose as a carrier for topical antimicrobials: first experience

Surg Infect (Larchmt). 2010 Feb;11(1):29-32. doi: 10.1089/sur.2008.093.

Abstract

Background: Micro-dispersed oxidized cellulose, already used for hemostasis, might be helpful for introduction of an antimicrobial drug.

Aim: To examine the effect of topically applied gentamicin attached to a new biodegradable carrier formed by micro-dispersed oxidized cellulose in microfiber and nanofiber form for treatment of acute wound infection and to assess the influence of this carrier on healing.

Materials and methods: A model of a full-thickness infected dermal wound was created in 12 female domestic pigs. The effectiveness of topical gentamicin delivered with micro-dispersed oxidized cellulose carrier was tested in acute wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa, or Escherichia coli.

Results: The effectiveness of nanofiber micro-dispersed oxidized cellulose with gentamicin was proved according to culture findings. When assessed macroscopically, 100% of wounds treated by the nanofiber product had no signs of local infection. When microfiber micro-dispersed oxidized cellulose was used, cultures demonstrated residual bacteria in 94.4% of treated incisions despite the absence of clinically recognized infection.

Conclusions: Micro-dispersed oxidized cellulose carrier with a sufficient concentration of an attached antibiotic appears to be effective for the treatment of full-thickness skin infections. The positive influence of the product on the healing of a dermal incision was shown, and a good hemostatic effect was confirmed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Infective Agents, Local / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Cellulose, Oxidized / administration & dosage*
  • Disease Models, Animal
  • Drug Carriers / administration & dosage*
  • Escherichia coli / drug effects
  • Escherichia coli / isolation & purification
  • Female
  • Gentamicins / therapeutic use*
  • Nanofibers / administration & dosage*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / isolation & purification
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / isolation & purification
  • Swine
  • Treatment Outcome
  • Wound Healing
  • Wound Infection / drug therapy*

Substances

  • Anti-Infective Agents, Local
  • Cellulose, Oxidized
  • Drug Carriers
  • Gentamicins